Israel-based pharma company PainReform completes two key capital markets issuances
Categories: Capital Markets
Israel-based public company, PainReform has completed two transactions, involving the registered direct offerings of ordinary shares and warrants, as well as a concurrent private placement of warrants.
PainReform is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics.
The matters were led by Greenberg Traurig Tel Aviv Shareholder Gary Emmanuel, with the support of NY Shareholders Mark Selinger and Eyal Peled, together with Tel Aviv attorneys Michael Soumas, Igal Rojzman and Devora Snyder-Shefer, and New York Law Clerk Anahita Mohtasham-Gharagozloo.
